{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:16:00Z","timestamp":1775654160921,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR51120\/AI\/133\/179\/2024"],"award-info":[{"award-number":["BT\/PR51120\/AI\/133\/179\/2024"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05209-y","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:01:35Z","timestamp":1759737695000},"page":"2353-2367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CT-based multimodal prediction model for chemotherapy response in gallbladder cancer: integration of imaging and clinical biomarkers\u2014a prospective pilot study"],"prefix":"10.1007","volume":"51","author":[{"given":"Kritika","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niharika","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakur","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lileswar","family":"Kaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Irrinki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhurima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parikshaa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aravind","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"5209_CR1","doi-asserted-by":"publisher","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer Nat Rev Dis Primers. 2022;8(1):69. Published 2022 Oct 27. https:\/\/doi.org\/10.1038\/s41572-022-00398-y","DOI":"10.1038\/s41572-022-00398-y"},{"issue":"4","key":"5209_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/cco.2019.08.03","volume":"8","author":"U Dutta","year":"2019","unstructured":"Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8(4):33.","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"5209_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12885-018-5211-y","volume":"19","author":"MS You","year":"2019","unstructured":"You MS, Ryu JK, Choi YH, Choi JH, Huh G, Paik WH, et al. Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin. BMC Cancer. 2019;19(1):10.","journal-title":"BMC Cancer"},{"issue":"3","key":"5209_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s00261-020-02756-4","volume":"46","author":"P Gupta","year":"2021","unstructured":"Gupta P, Meghashyam K, Marodia Y, Gupta V, Basher R, Das CK, et al. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol N Y. 2021;46(3):998\u20131007.","journal-title":"Abdom Radiol N Y"},{"issue":"8","key":"5209_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.bjc.6601736","volume":"90","author":"DC Doval","year":"2004","unstructured":"Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, et al. A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90(8):1516\u201320.","journal-title":"Br J Cancer"},{"issue":"1","key":"5209_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00280-017-3341-6","volume":"80","author":"Y Hirooka","year":"2017","unstructured":"Hirooka Y, Ishikawa T, Kawashima H, Ohno E, Nonogaki K, Kanamori A, et al. Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer. Cancer Chemother Pharmacol. 2017;80(1):119\u201325.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"5209_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","volume":"20","author":"VA Chaudhari","year":"2018","unstructured":"Chaudhari VA, Ostwal V, Patkar S, Sahu A, Toshniwal A, Ramaswamy A, et al. Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications. HPB. 2018;20(9):841\u20137.","journal-title":"HPB"},{"issue":"3","key":"5209_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00535-018-1518-3","volume":"54","author":"Y Suzuki","year":"2019","unstructured":"Suzuki Y, Kan M, Kimura G, Umemoto K, Watanabe K, Sasaki M, et al. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy. J Gastroenterol. 2019;54(3):281\u201390.","journal-title":"J Gastroenterol"},{"issue":"11","key":"5209_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4240\/wjgs.v14.i11.1272","volume":"14","author":"SR Sinha","year":"2022","unstructured":"Sinha SR, Prakash P, Singh RK, Sinha DK. Assessment of tumor markers CA 19\u2009\u2013\u20099, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. World J Gastrointest Surg. 2022;14(11):1272\u20131284. https:\/\/doi.org\/10.4240\/wjgs.v14.i11.1272","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"5209_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12885-020-07334-x","volume":"20","author":"A Sachan","year":"2020","unstructured":"Sachan A, Saluja SS, Nekarakanti PK, et al. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma. BMC Cancer. 2020;20(1):826. Published 2020 Aug 31. https:\/\/doi.org\/10.1186\/s12885-020-07334-x","journal-title":"BMC Cancer"},{"issue":"11","key":"5209_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.hpb.2017.06.011","volume":"19","author":"Z Wen","year":"2017","unstructured":"Wen Z, Si A, Yang J, et al. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma. HPB (Oxford). 2017;19(11):951\u2013956. https:\/\/doi.org\/10.1016\/j.hpb.2017.06.011","journal-title":"HPB (Oxford)"},{"issue":"7","key":"5209_CR12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1200\/JCO.23.01193","volume":"42","author":"V Ostwal","year":"2024","unstructured":"Ostwal V, Mandavkar S, Bhargava P, et al. Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Na\u00efve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB). J Clin Oncol. 2024;42(7):800\u2013807. https:\/\/doi.org\/10.1200\/JCO.23.01193","journal-title":"J Clin Oncol"},{"issue":"2","key":"5209_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"5209_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, et al. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer. 2016;62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"issue":"2","key":"5209_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","volume":"56","author":"D Schottenfeld","year":"2006","unstructured":"Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56(2):69\u201383. https:\/\/doi.org\/10.3322\/canjclin.56.2.69","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5209_CR16","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/hep.30493","volume":"69","author":"B Goeppert","year":"2019","unstructured":"Goeppert B, Toth R, Singer S, et al. Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma. Hepatology. 2019;69(5):2091\u20132106. https:\/\/doi.org\/10.1002\/hep.30493","journal-title":"Hepatology"},{"key":"5209_CR17","doi-asserted-by":"publisher","first-page":"111674","DOI":"10.1016\/j.mrfmmm.2019.111674","volume":"816\u2013818","author":"SK Mishra","year":"2019","unstructured":"Mishra SK, Kumari N, Krishnani N. Molecular pathogenesis of gallbladder cancer: An update. Mutat Res. 2019;816\u2013818:111674. https:\/\/doi.org\/10.1016\/j.mrfmmm.2019.111674","journal-title":"Mutat Res"},{"issue":"9","key":"5209_CR18","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.hpb.2019.01.014","volume":"21","author":"A Ruzzenente","year":"2019","unstructured":"Ruzzenente A, Bagante F, Ratti F, et al. Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases. HPB (Oxford). 2019;21(9):1230\u20131239. https:\/\/doi.org\/10.1016\/j.hpb.2019.01.014.","journal-title":"HPB (Oxford)"},{"key":"5209_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jss.2020.09.039","volume":"259","author":"W Ren","year":"2021","unstructured":"Ren W, Sell NM, Ferrone CR, Tanabe KK, Lillemoe KD, Qadan M. Size of the Largest Colorectal Liver Metastasis Is an Independent Prognostic Factor in the Neoadjuvant Setting. J Surg Res. 2021;259:253\u2013260. https:\/\/doi.org\/10.1016\/j.jss.2020.09.039","journal-title":"J Surg Res"},{"key":"5209_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/bs.pmbts.2018.12.011","volume":"162","author":"C Hao","year":"2019","unstructured":"Hao C, Zhang G, Zhang L. Serum CEA levels in 49 different types of cancer and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:213\u2013227. https:\/\/doi.org\/10.1016\/bs.pmbts.2018.12.011","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5209_CR21","doi-asserted-by":"publisher","unstructured":"Lei J, Wu L, Zhang N, et al. Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1\u0251 axis. Mol Biomed. 2024;5(1):19. Published 2024 May 24. https:\/\/doi.org\/10.1186\/s43556-024-00181-3","DOI":"10.1186\/s43556-024-00181-3"},{"key":"5209_CR22","doi-asserted-by":"publisher","first-page":"101179","DOI":"10.1016\/j.drup.2024.101179","volume":"78","author":"Y Chen","year":"2025","unstructured":"Chen Y, Mi Y, Tan S, et al. CEA-induced PI3K\/AKT pathway activation through the binding of CEA to KRT1 contributes to oxaliplatin resistance in gastric cancer. Drug Resist Updat. 2025;78:101179. https:\/\/doi.org\/10.1016\/j.drup.2024.101179","journal-title":"Drug Resist Updat"},{"issue":"2","key":"5209_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2022","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132\u2013146. https:\/\/doi.org\/10.1038\/s41571-021-00560-7","journal-title":"Nat Rev Clin Oncol"},{"key":"5209_CR24","doi-asserted-by":"publisher","unstructured":"Wu J, Zheng Z, Li J, Shen X, Huang B. Predicting treatment response to systemic therapy in advanced gallbladder cancer using multiphase enhanced CT images. Eur Radiol. Published online May 8, 2025. https:\/\/doi.org\/10.1007\/s00330-025-11645-7","DOI":"10.1007\/s00330-025-11645-7"},{"key":"5209_CR25","doi-asserted-by":"publisher","unstructured":"Cui Y, Zhang J, Li Z, et al. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study. EClinicalMedicine. 2022;46:101348. Published 2022 Mar 21. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101348","DOI":"10.1016\/j.eclinm.2022.101348"},{"issue":"3","key":"5209_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00535-018-1518-3","volume":"54","author":"Y Suzuki","year":"2019","unstructured":"Suzuki Y, Kan M, Kimura G, et al. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy. J Gastroenterol. 2019;54(3):281\u2013290. https:\/\/doi.org\/10.1007\/s00535-018-1518-3.","journal-title":"J Gastroenterol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05209-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:20:55Z","timestamp":1775650855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05209-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5209"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05209-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}